Russell Investments Group, Ltd. Greenwich Life Sciences, Inc. Transaction History
Russell Investments Group, Ltd.
- $84.2 Billion
- Q3 2025
A detailed history of Russell Investments Group, Ltd. transactions in Greenwich Life Sciences, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 649 shares of GLSI stock, worth $5,438. This represents 0.0% of its overall portfolio holdings.
Number of Shares
649
Previous 388
67.27%
Holding current value
$5,438
Previous $3,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding GLSI
# of Institutions
48Shares Held
1.16MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY309KShares$2.59 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA297KShares$2.49 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA142KShares$1.19 Million0.0% of portfolio
-
State Street Corp Boston, MA81.9KShares$686,7070.0% of portfolio
-
Northern Trust Corp Chicago, IL75.9KShares$636,0830.0% of portfolio
About Greenwich LifeSciences, Inc.
- Ticker GLSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,848,200
- Market Cap $108M
- Description
- Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...